Machine Learning: New Approach To Drug Discovery - Daphne Koller, Founder, Insitro

Machine Learning: New Approach to Drug Discovery - Daphne Koller, Founder, Insitro

Machine Learning: A New Approach to Drug Discovery | Daphne Koller | WiDS 2020

Daphne Koller: Machine Learning: A New Approach to Drug Discovery

Daphne Koller: How machine learning is transforming drug discovery

Stanford University School of Engineering

New Horizons in Generative AI: Machine Learning for Translatable Drug Discovery

Daphne Koller | Machine Learning: A New Approach to Drug Discovery | Stanford 2020

Women in Data Science Worldwide

Broad Institute Machine Learning in Drug Discovery Symposium 2023: Keynote - Daphne Koller

Broad Institute

Machine learning for drug discovery with insitro's Daphne Koller

Weights & Biases

Daphne Koller (insitro CEO) | On reimagining medicine with machine learning and data

Sana

Daphne Koller: AI-Driven Drug Discovery Using Digital Biology | TransformX 2022

Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332

The TWIML AI Podcast with Sam Charrington

E1089 Next Unicorns E11: insitro CEO Daphne Koller is optimizing drug discovery via machine learning

This Week in Startups

Machine learning: A New Approach to Drug Discovery | Daphne Koller | MIDL 2020

DSAI by Dr. Osbert Tay

Machine Learning: A new approach to drug discovery

Fields Institute

MIDL 2020, Keynote by Daphne Koller: Machine learning: a new approach to drug discovery

Daphne Koller, PhD: CEO and founder of insitro

ETL Speaker Series: Daphne Koller, insitro

Stanford eCorner

Targeting Therapeutic Hypothesis in Machine Learning | Daphne Koller, Ph.D., Founder & CEO, insitro

No Priors Ep. 6 | With Daphne Koller from Insitro

No Priors: AI, Machine Learning, Tech, & Startups

The Language of Digital Biology | Daphne Koller, Ph.D., Founder and CEO, insitro